Shingo Hatakeyama

3.7k total citations
188 papers, 2.6k citations indexed

About

Shingo Hatakeyama is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Shingo Hatakeyama has authored 188 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 71 papers in Surgery and 38 papers in Molecular Biology. Recurrent topics in Shingo Hatakeyama's work include Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (35 papers) and Prostate Cancer Treatment and Research (34 papers). Shingo Hatakeyama is often cited by papers focused on Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (35 papers) and Prostate Cancer Treatment and Research (34 papers). Shingo Hatakeyama collaborates with scholars based in Japan, United States and Taiwan. Shingo Hatakeyama's co-authors include Chikara Οhyama, Yasuhiro Hashimoto, Takuya Koie, Takahiro Yoneyama, Tohru Yoneyama, Hayato Yamamoto, Yuki Tobisawa, Minoru Fukuda, Teppei Okamoto and Tomonori Habuchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Shingo Hatakeyama

174 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Shingo Hatakeyama	961	842	675	473	418	188	2.6k
Howard Kynaston	1.2k 1.2×	1.3k 1.5×	1.2k 1.8×	914 1.9×	334 0.8×	111	4.0k
Jörg Fuchs	660 0.7×	837 1.0×	953 1.4×	518 1.1×	257 0.6×	171	3.0k
Lutz Trojan	1.0k 1.1×	1.9k 2.2×	662 1.0×	537 1.1×	299 0.7×	129	3.4k
Takefumi Satoh	878 0.9×	1.6k 1.9×	546 0.8×	665 1.4×	266 0.6×	157	3.6k
Yeong Jin Choi	691 0.7×	661 0.8×	783 1.2×	345 0.7×	421 1.0×	148	2.9k
Hayato Yamamoto	610 0.6×	738 0.9×	915 1.4×	387 0.8×	119 0.3×	196	2.5k
Wei Phin Tan	926 1.0×	892 1.1×	680 1.0×	1.2k 2.5×	448 1.1×	128	3.0k
Shinichi Yamashita	719 0.7×	968 1.1×	512 0.8×	411 0.9×	89 0.2×	154	2.2k
Patrick Guinan	1.0k 1.0×	1.4k 1.6×	732 1.1×	577 1.2×	314 0.8×	214	2.7k
David H. Wang	1.0k 1.1×	469 0.6×	1.4k 2.0×	507 1.1×	347 0.8×	71	3.1k

Countries citing papers authored by Shingo Hatakeyama

Since Specialization

Citations

This map shows the geographic impact of Shingo Hatakeyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Hatakeyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Hatakeyama more than expected).

Fields of papers citing papers by Shingo Hatakeyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Hatakeyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Hatakeyama. The network helps show where Shingo Hatakeyama may publish in the future.

Co-authorship network of co-authors of Shingo Hatakeyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Hatakeyama. A scholar is included among the top collaborators of Shingo Hatakeyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Hatakeyama. Shingo Hatakeyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saito, Mitsuru, Shinya Maita, Reiichi Murakami, et al.. (2025). Benefits of Preemptive Living Kidney Transplantation: Reduced Rates of Cerebro‐Cardiovascular Events and Neoplasm Development. International Journal of Urology. 32(12). 1843–1850.

Miura, Yuki, Tohru Yoneyama, Hayato Yamamoto, et al.. (2025). Analytical and Real‐World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population. The Prostate. 85(9). 869–887. 4 indexed citations

Yoneyama, Tohru, Yuki Miura, Akio Yoneyama, et al.. (2025). The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies. The Prostate. 85(11). 1062–1068. 3 indexed citations

Yanagisawa, Takafumi, Wataru Fukuokaya, Shingo Hatakeyama, et al.. (2024). Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study. The Prostate. 85(2). 165–174. 4 indexed citations

Fujita, Naoki, Masaki Momota, Yuki Tobisawa, et al.. (2023). Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study. The World Journal of Men s Health. 41(4). 900–900. 1 indexed citations

Fujita, Naoki, Hiroyuki Suganuma, Shingo Hatakeyama, et al.. (2023). Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction. The World Journal of Men s Health. 41(3). 701–701. 7 indexed citations

Shimizu, Sayaka, Yoshihiro Ônishi, Jui Wang, et al.. (2022). Cohort profile: Alliance for Quality Assessment in Healthcare-Dialysis (AQuAH-D) prospective cohort study of patients on haemodialysis in Japan. BMJ Open. 12(1). e054427–e054427. 2 indexed citations

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2022). Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high‐risk non‐muscle‐invasive bladder cancer who receive adjuvant induction bacillus Calmette‐Guérin therapy. International Journal of Urology. 29(8). 867–875. 1 indexed citations

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2022). Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study. The World Journal of Men s Health. 41(2). 373–373. 1 indexed citations

10.

Kato, Renpei, Sei Naito, Kazuyuki Numakura, et al.. (2022). Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study. International Journal of Clinical Oncology. 27(3). 563–573. 8 indexed citations

11.

Hatakeyama, Shingo, Hideo Kawaguchi, Yoshiomi Hatayama, et al.. (2021). Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study. Urologic Oncology Seminars and Original Investigations. 40(2). 64.e1–64.e8. 11 indexed citations

12.

Hatano, Koji, Tohru Yoneyama, Shingo Hatakeyama, et al.. (2021). Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer. British Journal of Cancer. 126(5). 764–770. 17 indexed citations

13.

Kubota, Yuka, Shingo Hatakeyama, Hayato Yamamoto, et al.. (2020). Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study. European Urology Open Science. 19. e311–e312. 2 indexed citations

14.

Yoneyama, Tohru, Daisuke Noro, Yuki Tobisawa, et al.. (2019). The Impact of Glycosylation of Osteopontin on Urinary Stone Formation. International Journal of Molecular Sciences. 21(1). 93–93. 15 indexed citations

15.

Yoneyama, Tohru, Yuki Tobisawa, Takatoshi Kaya, et al.. (2019). Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection. Cancer Science. 110(8). 2573–2589. 25 indexed citations

16.

Hatakeyama, Shingo, Atsushi Imai, Toshikazu Tanaka, et al.. (2018). Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan. British Journal of Urology. 123(5). 877–884. 27 indexed citations

17.

Noro, Daisuke, Tohru Yoneyama, Shingo Hatakeyama, et al.. (2017). Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant. International Journal of Molecular Sciences. 18(8). 1731–1731. 10 indexed citations

18.

Tobisawa, Yuki, Takatoshi Kaya, Shingo Hatakeyama, et al.. (2017). Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer. International Journal of Molecular Sciences. 18(2). 261–261. 33 indexed citations

19.

Yoneyama, Tohru, Yuki Tobisawa, Shingo Hatakeyama, et al.. (2017). An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis. International Journal of Molecular Sciences. 18(2). 470–470. 43 indexed citations

20.

Bao, Xingfeng, Motohiro Kobayashi, Shingo Hatakeyama, et al.. (2009). Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3- N -acetylglucosaminyltransferase. Proceedings of the National Academy of Sciences. 106(29). 12109–12114. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact